MedTrace Logo

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo

NCT02142283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2018-07-20

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the hypothesis that Trevo thrombectomy plus medical management leads to superior clinical outcomes at 90 days as compared to medical management alone in appropriately selected subjects experiencing an acute ischemic stroke when treatment is initiated within 6-24 hours after last seen well.

Conditions

Interventions

DEVICE

Trevo Thrombectomy Procedure

stent retriever; intended to restore blood flow in the neurovasculature by removing thrombus (clot)

OTHER

Medical Management

Standard of Care not including mechanical thrombectomy, no intra arterial treatment, may include aspirin, therapy etc

Sponsors & Collaborators

  • Stryker Neurovascular

    lead INDUSTRY

Principal Investigators

  • Tudor G Jovin, MD · University of Pittsburg Medical Center Stroke Institute

  • Raul Nogueira, MD · Marcus Stroke & Neuroscience Center, Grady Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-05-15
Completion
2017-05-15

Countries

  • United States
  • Australia
  • Canada
  • France
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02142283 on ClinicalTrials.gov